2018 Innovations in Stem Cell Therapy - Covering Renevia, Fujifilm, Osiris and Pluristem - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Innovations in Stem Cell Therapy” report has been added to ResearchAndMarkets.com’s offering.
This Genetic Technology TOE provides insights into recent developments across stem cell technologies. It encompasses innovations in delivery platforms, iPSC therapeutics, bioengineering methods, and mesenchymal stem cell therapies. The TOE also provides a summary of key stem cell therapies.
The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.
Companies FeaturedRenevia Fujifilm Osiris Pluristem
Key Topics Covered
1. Recent Advances in Stem Cell TechnologiesInjectable 3D Cell Delivery Matrix iPSCs Derived Cardiomyocytes for Heart Failure Bioengineered Stem Cell and Tissue-based Platforms Placenta-derived, Mesenchymal-like Adherent Stromal Cells
2. Clinical Trial Analysis and Key ContactsClinical Trial Analysis for Stem Cell Therapy Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/z6z2tq/2018_innovations?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005677/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Stem Cells
INDUSTRY KEYWORD: STEM CELLS HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/19/2018 01:41 PM/DISC: 09/19/2018 01:41 PM